Virginie Raynal

5.1k total citations · 1 hit paper
40 papers, 2.3k citations indexed

About

Virginie Raynal is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Virginie Raynal has authored 40 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Cancer Research and 14 papers in Hematology. Recurrent topics in Virginie Raynal's work include Blood groups and transfusion (13 papers), Erythrocyte Function and Pathophysiology (12 papers) and Neuroblastoma Research and Treatments (9 papers). Virginie Raynal is often cited by papers focused on Blood groups and transfusion (13 papers), Erythrocyte Function and Pathophysiology (12 papers) and Neuroblastoma Research and Treatments (9 papers). Virginie Raynal collaborates with scholars based in France, Morocco and Australia. Virginie Raynal's co-authors include Baya Chérif‐Zahar, Olivier Delattre, Gaëlle Pierron, Giorgio Matassi, Valérie Combaret, Isabelle Janoueix‐Lerosey, Gudrun Schleiermacher, Anne‐Marie Marini, Bruno André and Anne Vincent‐Salomon and has published in prestigious journals such as Nature, Nature Genetics and Blood.

In The Last Decade

Virginie Raynal

38 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

2008 622 citations Isabelle Janoueix‐Lerosey, Agnès Ribeiro et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Virginie Raynal France	26	1.1k	688	581	562	465	40	2.3k
Håkan Axelson Sweden	37	2.8k 2.5×	1.4k 2.1×	554 1.0×	885 1.6×	152 0.3×	90	4.1k
Jeffrey Ecsedy United States	32	2.0k 1.8×	361 0.5×	478 0.8×	1.6k 2.9×	204 0.4×	71	3.5k
Alexey A. Leontovich United States	28	1.3k 1.2×	312 0.5×	110 0.2×	689 1.2×	190 0.4×	60	2.6k
Andrew J. Mungall Canada	36	2.5k 2.3×	794 1.2×	206 0.4×	642 1.1×	138 0.3×	106	4.1k
Rani E. George United States	30	3.4k 3.1×	1.4k 2.0×	1.5k 2.5×	1.1k 1.9×	180 0.4×	55	4.9k
Robert Winqvist Finland	34	2.1k 1.9×	853 1.2×	214 0.4×	936 1.7×	275 0.6×	89	3.3k
Maria Luisa Sulis United States	19	2.2k 2.0×	367 0.5×	106 0.2×	638 1.1×	764 1.6×	52	3.2k
Jakob Lovén United States	15	2.5k 2.3×	636 0.9×	127 0.2×	435 0.8×	205 0.4×	17	3.1k
Thomas Look United States	19	2.1k 1.9×	308 0.4×	206 0.4×	882 1.6×	1.0k 2.2×	36	3.1k
Teresa Palomero United States	29	3.5k 3.1×	815 1.2×	131 0.2×	1.0k 1.8×	1.1k 2.4×	61	5.4k

Countries citing papers authored by Virginie Raynal

Since Specialization

Citations

This map shows the geographic impact of Virginie Raynal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Raynal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Raynal more than expected).

Fields of papers citing papers by Virginie Raynal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Raynal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Raynal. The network helps show where Virginie Raynal may publish in the future.

Co-authorship network of co-authors of Virginie Raynal

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Raynal. A scholar is included among the top collaborators of Virginie Raynal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Raynal. Virginie Raynal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiao, Yue, Laetitia Fuhrmann, Marie‐Gabrielle Dondon, et al.. (2025). Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile. Breast Cancer Research. 27(1). 36–36.

Jolly, Christopher A., Anne‐Sophie Macé, Gabriel Champenois, et al.. (2024). TFEB triggers a matrix degradation and invasion program in triple-negative breast cancer cells upon mTORC1 repression. Developmental Cell. 60(7). 1018–1035.e8. 3 indexed citations

Raynal, Virginie, Sylvain Baulande, Guillaume Bataillon, et al.. (2020). Lack of evidence for CDK12 as an ovarian cancer predisposing gene. Familial Cancer. 19(3). 203–209. 2 indexed citations

Popova, Tatiana, Élodie Manié, Valentina Boeva, et al.. (2016). Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications. Cancer Research. 76(7). 1882–1891. 79 indexed citations

Gruel, Nadège, Vanessa Benhamo, Jaydutt Bhalshankar, et al.. (2014). Polarity gene alterations in pure invasive micropapillary carcinomas of the breast. Breast Cancer Research. 16(3). R46–R46. 34 indexed citations

Boeva, Valentina, Stéphanie Jouannet, Romain Daveau, et al.. (2013). Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis. PLoS ONE. 8(8). e72182–e72182. 28 indexed citations

Mazot, Pierre, Alex Cazes, Marie‐Claude Boutterin, et al.. (2011). The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking. Oncogene. 30(17). 2017–2025. 46 indexed citations

Gravier, Eléonore, Gaëlle Pierron, Anne Vincent‐Salomon, et al.. (2010). A prognostic DNA signature for T1T2 node‐negative breast cancer patients. Genes Chromosomes and Cancer. 49(12). 1125–1134. 60 indexed citations

Gruel, Nadège, Carlo Lucchesi, Virginie Raynal, et al.. (2010). Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. European Journal of Cancer. 46(13). 2399–2407. 50 indexed citations

10.

Gravier, Eléonore, Gaëlle Pierron, Anne Vincent‐Salomon, et al.. (2010). 183 A DNA signature to identify high-risk small node-negative breast cancer patients. European Journal of Cancer Supplements. 8(3). 111–112. 1 indexed citations

11.

Bernard‐Pierrot, Isabelle, Nadège Gruel, Nicolas Stransky, et al.. (2008). Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer. Cancer Research. 68(17). 7165–7175. 73 indexed citations

12.

Vincent‐Salomon, Anne, Carlo Lucchesi, Nadège Gruel, et al.. (2008). Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast. Clinical Cancer Research. 14(7). 1956–1965. 114 indexed citations

13.

Vincent‐Salomon, Anne, Nadège Gruel, Carlo Lucchesi, et al.. (2007). Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Research. 9(2). R24–R24. 133 indexed citations

14.

Idbaïh, Ahmed, Yannick Marie, Carlo Lucchesi, et al.. (2007). BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. International Journal of Cancer. 122(8). 1778–1786. 88 indexed citations

15.

Schleiermacher, Gudrun, Franck Bourdeaut, Valérie Combaret, et al.. (2005). Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain. Oncogene. 24(20). 3377–3384. 24 indexed citations

16.

Chérif‐Zahar, Baya, Giorgio Matassi, Virginie Raynal, et al.. (1998). Molecular Defects of the RHCE Gene in Rh-Deficient Individuals of the Amorph Type. Blood. 92(2). 639–646. 3 indexed citations

17.

Chérif‐Zahar, Baya, V. Bony, Rudi Steffensen, et al.. (1998). Shift from Rh‐positive to Rh‐negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia. British Journal of Haematology. 102(5). 1263–1270. 17 indexed citations

18.

Matassi, Giorgio, Baya Chérif‐Zahar, Virginie Raynal, Philippe Rouger, & Jean‐Pierre Cartron. (1998). Organization of the HumanRH50AGene (RHAG) and Evolution of Base Composition of the RH Gene Family. Genomics. 47(2). 286–293. 36 indexed citations

19.

Chérif‐Zahar, Baya, et al.. (1994). Organization of the Gene (RHCE) Encoding the Human Blood Group RhCcEe Antigens and Characterization of the Promoter Region. Genomics. 19(1). 68–74. 99 indexed citations

20.

Chérif‐Zahar, Baya, Virginie Raynal, Caroline Le Van Kim, et al.. (1993). Structure and expression of the RH locus in the Rh-deficiency syndrome. Blood. 82(2). 656–662. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact